JPS57206624A - Immunological regulating agent - Google Patents
Immunological regulating agentInfo
- Publication number
- JPS57206624A JPS57206624A JP56091603A JP9160381A JPS57206624A JP S57206624 A JPS57206624 A JP S57206624A JP 56091603 A JP56091603 A JP 56091603A JP 9160381 A JP9160381 A JP 9160381A JP S57206624 A JPS57206624 A JP S57206624A
- Authority
- JP
- Japan
- Prior art keywords
- immunological
- diseases
- reducing
- normal value
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PURPOSE: An immunological regulating agent, containing lysozyme chloride as an active constituent, capable of reducing the abnormal producion of an antibody to the normal value, and useful for the treatment of automimmune diseases causing the abnormality in the immunological function without side effects.
CONSTITUTION: An immunological regulating agent containing lysozyme chloride e.g. a hen's egg white hysozyme as an active constituent. For example, the hen's egg white is a basic polypeptide consisting of 129 amino acids, and having a molecular weight of 14,300, relatively stable to acids, and recognized to have an anti-inflammatory, antiallergic and immunological activating actions, etc. Furtheremore, the activity of reducing the abnormal production of antibody in diseases, e.g. Hashimoto or collagen diseases, to the normal value other than the immunological activating action is found. In the diseases, so-called autoimmune diseases, the antibody production, i.e. the function of B cells, is enhanced due to the hypofunction of the suppressor T cells; however, the lysozyme is capable of reducing the immunity to the normal value without causing side effects, e.g. abnormal reduction or edema.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56091603A JPS57206624A (en) | 1981-06-16 | 1981-06-16 | Immunological regulating agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56091603A JPS57206624A (en) | 1981-06-16 | 1981-06-16 | Immunological regulating agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57206624A true JPS57206624A (en) | 1982-12-18 |
JPH0210807B2 JPH0210807B2 (en) | 1990-03-09 |
Family
ID=14031127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56091603A Granted JPS57206624A (en) | 1981-06-16 | 1981-06-16 | Immunological regulating agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57206624A (en) |
-
1981
- 1981-06-16 JP JP56091603A patent/JPS57206624A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH0210807B2 (en) | 1990-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3484391D1 (en) | PRODUCTION OF PEPTIDES AND THEIR USE. | |
EP0132732A3 (en) | Homologues from aprotinine whose lys 15 amino acid is substituted by other amino acids, process for their preparation and their use as medicaments | |
IE811716L (en) | Lipstick | |
ES458691A1 (en) | Polypeptide | |
GB2191606B (en) | Active control of unsteady motion phenomena in turbomachinery | |
FI883688A0 (en) | MOLEKYLAER KLONING OCH EXPRESSION AV HUMANT INTERLEUKIN-3. | |
DK0631772T3 (en) | Retinoid-containing composition | |
ATE63750T1 (en) | PEPTIDE, ITS PRODUCTION AND USE. | |
GR861148B (en) | Tablets comprising tromethoprim and a sulfonamide | |
MY102292A (en) | Mode conversion of computer commands | |
EP0225020A3 (en) | Peptides comprising, in sequence, units selected from the amino-acid residues 17 to 24 of vip | |
JPS57206624A (en) | Immunological regulating agent | |
IT1251226B (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING CLOZAPINE, THEIR PREPARATION AND THEIR USE | |
JPS57134419A (en) | Stable anticoagulant of blood | |
IE40035L (en) | Modified gelatin blood plasma substitute. | |
ATE43137T1 (en) | PRODUCTION OF FREE-FLOWING PARTICULATE YEAST. | |
AU1543283A (en) | Biostimulating agent containing creatine | |
JPS56156211A (en) | Preparation of stable allantoin pharmaceutical | |
ATE24716T1 (en) | LENKOTRIAL ANTAGONISTS. | |
ATE187326T1 (en) | NON-IRRITATIVE AQUEOUS LIPOSOME DISPERSION CONTAINING ALPHA-HYDROXYCARBOXYLIC ACIDS AND/OR SALICYL ACIDS IN THEIR SALT FORM | |
ATA188385A (en) | USE OF PEROXYDIPHOSPHATES FOR THE PRODUCTION OF PHARMACEUTICAL TABLETS OR. PHARMACEUTICAL AQUEOUS SOLUTIONS | |
JPS5325561A (en) | Optical active lactam-2-acetic acid esters and their preparation | |
JPS55150857A (en) | Preparation of gluten paste | |
Smirnova | Effect of histamine and prostaglandins E2 and F2 alpha on the electrical activity of stomach cells in the rat | |
FR2522656B1 (en) | TAURIN SUBSTITUTED SOMATOSTATIN ANALOGS AND MEDICINES, ESPECIALLY USEFUL FOR THE TREATMENT OF DIABETES, CONTAINING |